Soleno Therapeutics, Inc. (SLNO) Financials
SLNO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 180.7 million | 23.2 million |
2023-09-30 | 63.5 million | 40.3 million |
2023-06-30 | 30.9 million | 18.5 million |
2023-03-31 | 19.5 million | 16.9 million |
SLNO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.3 million | 1.9 million |
2023-09-30 | -6.3 million | 2.2 million |
2023-06-30 | -5.6 million | 1.2 million |
2023-03-31 | -6.7 million | 631000 |
SLNO Net Income
No data available :(
SLNO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 169.7 million | - | 403000 |
2023-09-30 | 52.4 million | - | 470000 |
2023-06-30 | 19.4 million | - | 485000 |
2023-03-31 | 7.9 million | - | 39000 |
SLNO Shares Outstanding
SLNO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 8.7 million | 4.1 million | 489000 |
2023-09-30 | - | 6.0 million | 3.3 million | - |
2023-06-30 | - | 5.1 million | 3.2 million | - |
2023-03-31 | - | 5.3 million | 2.9 million | - |
SLNO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 489000 |
2023-09-30 | - | 557000 |
2023-06-30 | - | 598000 |
2023-03-31 | - | 568000 |
SLNO
Price: $45.12
52 week price:
Earnings Per Share: -2.36 USD
P/E Ratio: -15.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 110100
Ebitda: -13.8 millionMarket Capitalization: 1.3 billion